Listen to Podcast
Listen to Podcast

CMC and Bioprocessing

Mastering CMC and Bioprocess Complexity from Lab to Clinic

The Go-to CMC and Biomanufacturing Podcast for Bioprocess Development and Manufacturing Leaders

Listen to Podcast

2,500+ monthly downloads

ABOUT THE PODCAST

The Go-to CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders

Are you a process development scientist or CMC leader navigating scale- up, tech transfer, GMP readiness, or process validation across upstream and downstream development?
Are you selecting a CDMO partner and want to avoid costly surprises in tech transfer and manufacturing execution?
Are you a biotech founder preparing for an IND or Series A and need a CMC strategy that holds up under investor and regulatory scrutiny, without costly trial and error?
There is a more direct path. Practical, execution-focused guidance on the decisions that actually move programs forward, from lab to clinic to commercial scale.
Learn how leading CMC scientists and manufacturing executives do it.

What You Will Learn

  • How to build and execute a CMC strategy that satisfies regulators and investors
  • How to scale upstream and downstream bioprocesses for GMP manufacturing and successful process validation
  • How to approach CDMO selection and manage CDMO partnerships without costly surprises
  • How to reduce the cost of goods and manufacturing complexity through smarter process development

Latest Episodes

Stay ahead with our most recent technical deep dives.

Listen to the Podcast

Subscribe to the Smart Biotech Scientist podcast on your favorite platform.

your Strategic Bioprocess Development Advisor

Dr. David Brühlmann

Dr. David Brühlmann is a bioprocess innovator who specializes in transforming high-potential biotech discovery into scalable, investor-ready manufacturing reality. With over 15 years of experience, he has led global technology transfers and scaled processes up to 15,000 L for commercial production across Europe, North America, and Asia.

As the host of the Smart Biotech Scientist podcast, David has interviewed over 100 industry leaders, maintaining a strategic network that bridges the gap between complex CMC strategy and capital partners. He focuses on de-risking the path to Series A/B funding by aligning scientific innovation with rigorous, globally accessible manufacturing roadmaps.

David’s work ensures that life-saving therapies don’t just succeed in the lab, but reach patients through precision-engineered, large-scale execution.

your Strategic Bioprocess Development Advisor

Dr. David Brühlmann

Dr. David Brühlmann is a bioprocess innovator who specializes in transforming high-potential biotech discovery into scalable, investor-ready manufacturing reality. With over 15 years of experience, he has led global technology transfers and scaled processes up to 15,000 L for commercial production across Europe, North America, and Asia.

As the host of the Smart Biotech Scientist podcast, David has interviewed over 100 industry leaders, maintaining a strategic network that bridges the gap between complex CMC strategy and capital partners. He focuses on de-risking the path to Series A/B funding by aligning scientific innovation with rigorous, globally accessible manufacturing roadmaps.

David’s work ensures that life-saving therapies don’t just succeed in the lab, but reach patients through precision-engineered, large-scale execution.

The Bioprocess Brief — biweekly intelligence for CMC and manufacturing leaders.

Strategic takeaways on biologics, cell and gene therapies, and AI-driven bioprocessing — distilled from the Smart Biotech Scientist Podcast and 20+ years on the floor.

No spam. Unsubscribe anytime.

The Bioprocess Brief — biweekly intelligence for CMC and manufacturing leaders.

Strategic takeaways on biologics, cell and gene therapies, and AI-driven bioprocessing — distilled from the Smart Biotech Scientist Podcast and 20+ years on the floor.

No spam. Unsubscribe anytime.

The Bioprocess Brief — biweekly intelligence for CMC and manufacturing leaders.

Strategic takeaways on biologics, cell and gene therapies, and AI-driven bioprocessing — distilled from the Smart Biotech Scientist Podcast and 20+ years on the floor.

No spam. Unsubscribe anytime.